What Are the Uses of Urine Therapy for Cancer?

Cancer urine test reagent, a cancer urine test reagent for early detection of tumors, was successfully developed in 2005 after more than ten years, and has been approved by the State Food and Drug Administration. Product name: p-hydroxyphenylalanine (tyrosine) urine detection reagent, early detection and early screening is the key to treating tumors. The development of tumor is divided into 5 stages: benign, tumor cell initiation stage, early tumor stage, intermediate tumor stage, and advanced stage.

Cancer urine test

This entry lacks an overview map . Supplementing related content makes the entry more complete and can be upgraded quickly. Come on!

Cancer urine test reagent, a cancer urine test reagent for early detection of tumors, was successfully developed in 2005 after more than ten years, and has been approved by the State Food and Drug Administration. Product name: p-hydroxyphenylalanine (tyrosine) urine detection reagent, early detection and early screening is the key to treating tumors. The development of tumor is divided into 5 stages: benign, tumor cell initiation stage, early tumor stage, intermediate tumor stage, and advanced stage.

Chinese name

P-hydroxyphenylalanine (tyrosine) urine test reagent

Foreign name

Hydroxyl Phenylalanine (Tyrosine) Urine Detecting

Features

Safe and easy to use

Features

Cost-saving, efficient and accurate

Cancer, early detection and early treatment in the first 4 stages of development, can be completely cured, and found and treated in the first three stages, the cure rate can reach 100%. The terrible thing about cancer is that the first three stages cannot be detected by imaging. Even in the middle stage of the tumor, only very professional doctors can detect it with more advanced equipment. Research by the World Health Organization believes that: 1/3 of cancers can be prevented; 1/3 of cancers can prolong patients' lives through active treatment; 1/3 of cancers can be cured through early detection, early diagnosis, and early treatment . This means that early detection of tumors is possible.

Because early detection of cancer is very difficult and its fatality rate is high, most cancers are already in the middle and late stages of detection. The figures published by the World Health Organization's Cancer Research Center indicate that by 2020, there will be a 43% increase in cancer patients. According to the data of the Department of Disease Control and Prevention of the Ministry of Health of China, there are about 2 million tumors and 1.4 million deaths in China every year, which is increasing year by year.

12.01 million people worldwide have been diagnosed with cancer and 7.6 million people have died of cancer. In 2011, the new incidence rate in China was 2 million. At present, the new incidence rate of tumors in our country is 285.91 per 100,000. On average, 6 people are diagnosed as malignant every minute. For tumors, experts believe that 40% of cancers have potential for prevention.

Breast cancer, lung cancer, and colon cancer are becoming younger. The incidence of childhood cancer is increasing year by year. Statistics from the International Alliance Against Cancer indicate that the incidence of childhood cancer is about 1 in 10,000. Every year, 160,000 children worldwide are diagnosed with cancer, about 9 More than 10,000 people died of illness.

According to a survey report by the Ministry of Health of China, cancer has surpassed cardiovascular and cerebrovascular diseases as the most important condition that causes death in urban and rural residents in China. In the past 20 years, one in every 4-5 deaths in China has been caused by cancer, which is the leading cause of death. So cancer has become a common and frequently-occurring disease.

Cancer urine test reagents can be accurately detected through urine in the tumor cell initiation stage, early stage of tumor, and middle stage of tumor (benign phase is no longer monitored). The method is simple and accurate, and it is actively treated for people. Won the time. "

Cancer urine test reagents have a wide range of applications, and are suitable for cancer screening, screening and detection in all countries and regions. It can be used for the detection of the treatment effect of cancer patients and the follow-up monitoring of cancer rehabilitation patients.

In 1986, the Chernobyl accident broke out, and the Soviet Academy of Sciences put forward a theory for the development of cancer detection reagents;

After the disintegration of the Soviet Union in 1991, scientists involved in research and development brought this theory to Wuhan University for further research and development;

In 1992, a special task force was set up to carry out research and development of p-hydroxyphenylalanine (tyrosine) urine test reagents;

In 2006, after nearly 15 years of R & D, preliminary R & D was completed;

In 2009, the clinical trials in many hospitals across the country were officially completed and received good responses;

In 2010, proceeded with the application for invention patents and the approval of various national qualification certificates;

In 2013, it was included in the National Catalogue of Clinical Inspection Projects of Medical Institutions (2013 Edition) by the National Health and Family Planning Commission;

In the same year, the National Office of Chronic Disease Control Engineering issued a notice, which will be used as the main method and method for screening high-risk cancer populations in key regions of the country;